Free Trial

Extendicare (EXE) Competitors

Extendicare logo
C$13.39 -0.09 (-0.67%)
As of 01:02 PM Eastern

EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BLU, TRIL, and BHC

Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Bausch Health Companies (BHC). These companies are all part of the "medical" sector.

Extendicare vs. Its Competitors

Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Extendicare4.48% 64.13% 7.16%
dentalcorp -5.40%-4.71%0.77%

Extendicare currently has a consensus price target of C$14.15, indicating a potential upside of 5.68%. dentalcorp has a consensus price target of C$12.82, indicating a potential upside of 57.90%. Given dentalcorp's stronger consensus rating and higher possible upside, analysts plainly believe dentalcorp is more favorable than Extendicare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Extendicare
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.60
dentalcorp
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Extendicare has higher earnings, but lower revenue than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExtendicareC$1.46B0.77C$65.46MC$0.7817.07
dentalcorpC$1.49B1.02-C$80.68M-C$0.43-18.88

In the previous week, Extendicare had 8 more articles in the media than dentalcorp. MarketBeat recorded 10 mentions for Extendicare and 2 mentions for dentalcorp. Extendicare's average media sentiment score of 0.86 beat dentalcorp's score of 0.51 indicating that Extendicare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Extendicare
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
dentalcorp
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

19.2% of Extendicare shares are held by institutional investors. Comparatively, 50.3% of dentalcorp shares are held by institutional investors. 13.9% of Extendicare shares are held by insiders. Comparatively, 0.2% of dentalcorp shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Extendicare has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, dentalcorp has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Summary

Extendicare beats dentalcorp on 10 of the 16 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXE vs. The Competition

MetricExtendicareMedical Care Facilities IndustryMedical SectorTSE Exchange
Market CapC$1.12BC$1.46BC$5.69BC$6.38B
Dividend Yield4.42%4.04%4.61%6.72%
P/E Ratio17.076.9130.6667.52
Price / Sales0.7714.07465.141,616.41
Price / Cash3.2012.3238.2183.29
Price / Book9.601.929.014.90
Net IncomeC$65.46MC$58.06MC$3.25BC$301.20M
7 Day Performance1.67%0.83%4.84%1.19%
1 Month Performance2.76%-0.10%6.85%2.51%
1 Year Performance62.30%33.64%30.51%28.25%

Extendicare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXE
Extendicare
1.5241 of 5 stars
C$13.39
-0.7%
C$14.15
+5.7%
+63.8%C$1.12BC$1.46B17.0723,000
DNTL
dentalcorp
2.1644 of 5 stars
C$8.13
+2.7%
C$12.59
+54.9%
-3.1%C$1.53BC$1.49B-18.909,950
SIA
Sienna Senior Living
0.4909 of 5 stars
C$18.10
+1.0%
C$18.79
+3.8%
+22.3%C$1.50BC$938.65M44.8112,000News Coverage
Analyst Forecast
Analyst Revision
WELL
WELL Health Technologies
2.2106 of 5 stars
C$4.66
+0.6%
C$8.08
+73.3%
+5.9%C$1.16BC$962.00M15.79510News Coverage
Gap Up
DR
Medical Facilities
N/AC$14.69
+1.6%
C$14.75
+0.4%
+6.1%C$239.00MC$388.07M9.831,833
KDA
KDA Group
N/AC$0.28
+3.7%
N/A+10.2%C$49.11MC$28.71M-7.503,100
NLH
Nova Leap Health
N/AC$0.25
+11.1%
N/A+0.0%C$14.21MC$16.71M-30.81N/A
PHA
Premier Health of America
N/AC$0.04
flat
N/A-88.2%C$2.22MC$158.32M-0.18N/AGap Up
BLU
BELLUS Health
N/AN/AN/AN/AC$2.47BC$16K-20.2974
TRIL
Trillium Therapeutics
N/AN/AN/AN/AC$2.45BC$43K-34.0633
BHC
Bausch Health Companies
N/AC$8.30
+5.2%
N/A+36.6%C$2.16BC$6.69B-12.1519,900News Coverage

Related Companies and Tools


This page (TSE:EXE) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners